SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 92 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $24,000 | -93.4% | 212,947 | +0.4% | 0.00% | -100.0% |
| Q3 2018 | $361,000 | -1.6% | 212,200 | +0.6% | 0.00% | 0.0% |
| Q2 2018 | $367,000 | +4.9% | 211,000 | +10.5% | 0.00% | 0.0% |
| Q1 2018 | $350,000 | -22.4% | 191,000 | -10.1% | 0.00% | 0.0% |
| Q4 2017 | $451,000 | -1.5% | 212,500 | +34.5% | 0.00% | -50.0% |
| Q3 2017 | $458,000 | +31.2% | 158,000 | +101.3% | 0.00% | +100.0% |
| Q2 2017 | $349,000 | – | 78,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
| Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
| WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
| BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
| Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
| Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
| BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
| HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
| BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |